Follow
umit tursen
umit tursen
Mersin Üniversitesi Dermatoloji Bölümü
Verified email at mersin.edu.tr - Homepage
Title
Cited by
Cited by
Year
Clinical manifestations of Behçet's disease: an analysis of 2147 patients
A Gurler, A Boyvat, U Tursen
Yonsei medical journal 38 (6), 423-427, 1997
5101997
Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet's disease
U Tursen, A Gurler, A Boyvat
International journal of dermatology 42 (5), 346-351, 2003
5052003
Clinical features and natural course of Behçet’s disease in 661 cases: a multicentre study
E Alpsoy, L Donmez, M Onder, S Gunasti, A Usta, Y Karincaoglu, B Kandi, ...
British Journal of Dermatology 157 (5), 901-906, 2007
3422007
Demographic and clinical properties of juvenile-onset Behçet's disease: A controlled multicenter study
Y Karincaoglu, M Borlu, SC Toker, A Akman, M Onder, S Gunasti, A Usta, ...
Journal of the American Academy of Dermatology 58 (4), 579-584, 2008
2322008
Clinical improvement in chronic plaque‐type psoriasis lesions after narrow‐band UVB therapy is accompanied by a decrease in the expression of IFN‐γ inducers–IL‐12, IL‐18 and IL‐23
G Piskin, U Tursen, RMR Sylva‐Steenland, JD Bos, MBM Teunissen
Experimental dermatology 13 (12), 764-772, 2004
2232004
The evaluation of the sociodemographic and clinical features of Turkish psoriasis patients
N Kundakci, Ü Türsen, MOA Babiker, E Gürgey
International journal of dermatology 41 (4), 220-224, 2002
1852002
The prevalence of pediculosis capitis in schoolchildren in Mersin, Turkey
A Kokturk, K Baz, R Bugdayci, T Sasmaz, U Tursen, TI Kaya, G Ikizoglu
International journal of dermatology 42 (9), 694-698, 2003
1442003
Cutaneous manifestations in hospitalized patients diagnosed as COVID‐19
O Askin, RN Altunkalem, DD Altinisik, TK Uzuncakmak, U Tursen, ...
Dermatologic Therapy 33 (6), e13896, 2020
952020
Oxidant/antioxidant status in patients with recurrent aphthous stomatitis
MYB Cimen, TI Kaya, G Eskandari, U Tursen, G Ikizoglu, U Atik
Clinical and Experimental Dermatology 28 (6), 647-650, 2003
932003
Cutaneous sıde‐effects of the potential COVID‐19 drugs
Ü Türsen, B Türsen, T Lotti
Dermatologic therapy 33 (4), e13476, 2020
912020
D‐penicillamine treatment for lipoid proteinosis
TI Kaya, A Kokturk, U Tursen, G Ikizoglu, A Polat
Pediatric dermatology 19 (4), 359-362, 2002
882002
Pathophysiology of the Behcet's Disease
Ü Türsen
Pathology research international 2012, 2012
812012
Association of class I HLA antigens with the clinical manifestations of Turkish patients with Behçet's disease
TI Kaya, U Tursen, A Gurler, H Dur
Clinical and experimental dermatology 27 (6), 498-501, 2002
782002
The changes in expression of ICAM-3, Ki-67, PCNA, and CD31 in psoriatic lesions before and after methotrexate treatment
AC Yazici, U Tursen, DD Apa, G Ikizoglu, H Api, K Baz, B Tasdelen
Archives of dermatological research 297, 249-255, 2005
722005
Relationship between ABO blood groups and skin cancers
U Tursen, EN Tiftik, S Unal, O Gunduz, TI Kaya, H Camdeviren, G Ikizoglu
Dermatology online journal 11 (3), 2005
662005
Association between catechol-O-methyltransferase polymorphism and vitiligo
Ü Türsen, T Kaya, EM Erdal, E Derici, Ö Gündüz, G Ikizoglu
Archives of dermatological research 294 (3), 143, 2002
612002
Cutaneous manifestations of COVID‐19: a review of the published literature
ÖF Elmas, A Demirbaş, K Özyurt, M Atasoy, Ü Türsen
Dermatologic therapy 33 (4), e13696, 2020
602020
Psoriasis and COVID‐19: a narrative review with treatment considerations
ÖF Elmas, A Demirbaş, Ö Kutlu, F Bağcıer, MS Metin, K Özyurt, N Akdeniz, ...
Dermatologic Therapy 33 (6), e13858, 2020
542020
Treatment of lichen planopilaris with mycophenolate mofetil
U Tursen, H Api, T Kaya, G Ikizoglu
Dermatology online journal 10 (1), 2004
532004
Mycosis fungoides and Sezary syndrome: therapeutic approach and outcome in 113 patients
RY Anadolu, A Birol, H Sanlı, C Erdem, Ü Türsen
International journal of dermatology 44 (7), 559-565, 2005
492005
The system can't perform the operation now. Try again later.
Articles 1–20